Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
Pilot Study of Hepatic Arterial Infusion Therapy in Patients With Unresectable or Borderline Resectable Intrahepatic Cholangiocarcinoma
Sponsor: Washington University School of Medicine
A PHASE1 clinical study on Cholangiocarcinoma and Liver Neoplasms, this trial is terminated or withdrawn. The trial is conducted by Washington University School of Medicine and has accumulated 15 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Sep 2022 — Jul 2024 [monthly]
Terminated PHASE1
Status: Active Not Recruiting → Terminated
-
Apr 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE1
▶ Show 10 earlier versions
-
Apr 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE1
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting PHASE1
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Apr 2019 — Apr 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jul 2018 — Apr 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1
-
Apr 2018 — Jun 2018 [monthly]
Recruiting PHASE1
-
Aug 2017 — Apr 2018 [monthly]
Recruiting PHASE1
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • St Louis, United States